CHERYL NICKOLAOU: Open Payments
NPI 1821466277 · BURTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 41 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $411 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $167 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $144 |
| GlaxoSmithKline, LLC. | 2 | $137 |
| AstraZeneca Pharmaceuticals LP | 5 | $88 |
| Otsuka America Pharmaceutical, Inc. | 2 | $57 |
| Amgen Inc. | 3 | $52 |
| Exact Sciences Corporation | 2 | $44 |
| Novo Nordisk Inc | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $17 |
Products named: XIFAXAN, AREXVY, VRAYLAR, BREZTRI, REXULTI, OTEZLA, The Cologuard Plus Collection Kit, UBRELVY.
Industry payments across MI — which companies pay providers there.
